SureTrader SureTrader
Home > Boards > US OTC > Delisted >

Cytogenix (fka CYGX)

RSS Feed
Add Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board:
Last Post: 4/2/2016 11:10:59 PM - Followers: 156 - Board type: Free - Posts Today: 0

CytoGenix, Inc.
Phone: (830) 632-5944
Fax: (830) 632-5944

CytoGenix is a Nevada public corporation traded under the symbol CYGX.PK.

http://www.pr-inside.com/cytogenix-inc-to-become-sec-compliant-r2160873.htm

Email: info@cytogenix.com

Transfer Agent

Our Transfer Agent is Nevada Agency and Trust Company. Shareholders of record with questions about lost certificates, notification of change of address, or other matters should contact:

Nevada Agency and Trust Company
50 West Liberty, Suite 880
Reno, Nevada, 89501
(775) 322-0626 Telephone
(775) 332-5623 Fax
www.natco.org


 Expansion is in our forecast...



CYTOGENIX MISSION STATEMENT
"Our mission is to create human benefit and monetary value by developing biopharmaceutical agents that regulate genes to cure the root cause of disease rather than ameliorate symptoms.We will adhere to the highest ethical and scientific standards of conduct in our dealings with investors, employees, outside scientists and clinicians, the public and government regulatory agencies." "CytoGenix, Inc., with headquarters in Houston, Texas, is dedicated to developing biopharmaceutical compounds and services based on its proprietary gene regulating technology. We control U.S. and foreign patents for a technology that is effective in targeting and reducing gene expression. We have applied this technology to the development of topical compounds for the treatment of skin diseases and disorders such as, Herpes, Alopecia, Psoriasis, and contact dermatitis." Recently, CytoGenix Inc. Invents Revolutionary Large-Scale Manufacturing Process for High-Purity DNA."

http://cytogenix.com/index.html

Management
   
 
 
 
 
John J. Rossi, PhD 
Kevin Cassidy
 
Frédéric Kendirgi, PhD
 
Cory Huang, MS, MA, MBA
 
Jett
 
Cy A. Stein, MD PhD

Peter Glazer, MD, PhD
 
Steven Udem, MD

Sergio Rosini, PhD
 
Campbell Murray, MD

http://ih.advfn.com/p.php?pid=nmona&article=44863243&symbol=CYGX

Biotech Research and Others


J.M. Dutton & Assoc.- http://www.jmdutton.com/Research/CYGX/Index.html

Clinical Trials Info - http://www.centerwatch.com/
GenomeWeb - http://www.genomeweb.com/
News - http://www.biospace.com/
http://www.loonycat.com/Genomics.htm
Drug Approval Site http://www.fda.gov/cder/approval/index.htm
Linfield College Chemistry Dept. http://www.linfield.edu/chem/chemlinks.html#National
Biodefense Website - http://www.healthtech.com/2002/btr/
Center for Disease Control http://www.cdc.gov/
http://www.investorshub.com/boards/read_msg.asp?message_id=81022


Technical Analysis Link

http://www.stockta.com/cgi-bin/analysis.pl?symb=CYGX&num1=7&cobrand=

http://www.americanbulls.net/StockPage.asp?CompanyTicker=CYGX&MarketTicker=OTC&TYP=S

http://charts3.barchart.com/chart.asp?sym=CYGX&data=A&jav=adv&vol=Y&evnt=adv&gri....

http://www.tradingday.com/

http://www.best-charts.com/

A site to learn how to chart
http://www.stockcharts.com/education/ 
 

CytoGenix, Inc. is a Houston-based biopharmaceutical company pioneering the new field of gene based medicine and is focused on developing innovative vaccines and therapeutic products using its three proprietary technology platforms: synDNATM non-bacterial production methodology, single stranded DNA (ssDNA) expression, and oligonucleotide based anti-bacterial technologies. CytoGenix currently holds 13 granted patents and 57 international or US pending patent applications claiming methods and materials in connection with these platform technologies.

SAFE HARBOR: Except for statements of historical fact, the statements in this press release are forward-looking. Such statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from the statements made. These factors include, but are not limited to, general economic conditions, risks associated with the acceptance of new products, competition, and other factors more fully detailed in the Company's filings with the Securities and Exchange Commission. Additional information about CytoGenix and its technology can be found on the website at www.cytogenix.com. 

PostSubject
#64728   Anyone heard of any legal proceedings directed at RDOG 04/02/16 11:10:59 PM
#64727   Hey Paulness, I am just writing to say holycow 03/12/16 09:10:33 PM
#64726   Michael Skillern is going to prison truthhurts 02/09/16 02:38:46 AM
#64725   Ok...one more time... truthhurts 02/09/16 02:23:16 AM
#64724   Tax filing season is near. To the knowledgeable nw_La 02/02/16 04:07:54 PM
#64723   PVCT provectus looks to have great news in Paulness 09/16/15 07:36:08 AM
#64722   Paulness 09/10/15 02:36:22 PM
#64721   Been thinking of you and if you have Paulness 08/24/15 10:20:35 PM
#64720   Hymel & Skolnick Back Together Again truthhurts 07/02/15 06:11:38 AM
#64719   Sertant Website truthhurts 06/25/15 02:50:34 AM
#64718   Qbit & Sertant truthhurts 06/23/15 05:59:06 AM
#64717   I guess that it's all over and that nw_La 06/10/15 04:15:14 PM
#64716   Interesting news. I always wondered what Vazquez and Roscoe85 05/19/15 11:26:07 AM
#64715   Thanks for the update, the technology will hopefully Paulness 05/18/15 09:24:57 PM
#64714   We are contacting you in advance of a Hardthought 05/18/15 02:32:12 PM
#64713   :LooWe are contacting you in advance of a Hardthought 05/18/15 02:27:34 PM
#64712   I wonder how the shareholders.... truthhurts 01/01/15 06:45:03 AM
#64711   CYGX: SEC Litigation: Renee 12/18/14 09:21:18 AM
#64710   Sure....there is still 'hope'. truthhurts 10/03/14 05:23:55 AM
#64709   Just thinking out loud, and we all know Paulness 09/23/14 09:19:38 PM
#64708   Aren't these just charges truthhurts, I can find gzone 09/03/14 10:27:20 AM
#64707   'Time will tell' truthhurts 09/03/14 03:25:42 AM
#64706   I don't know any specifics gdepc, I checked gzone 08/15/14 12:48:43 PM
#64705   "they are working hard to get CYGX listed again" truthhurts 08/15/14 11:50:00 AM
#64704   Looks like the major shareholders see this as Paulness 08/14/14 11:06:48 PM
#64703   WOW checking in and saw the Plummer Cowsert news. gdepc 08/14/14 07:00:04 PM
#64702   Thanks truthhurts, for posting this information. It looks gzone 08/14/14 11:12:04 AM
#64701   "Some of the major stockholders..... truthhurts 08/13/14 04:28:41 PM
#64700   Thanks Pauless and you too. g gzone 08/10/14 10:48:54 PM
#64699   Yes I also received my email with the Paulness 08/10/14 07:53:54 PM
#64698   Thanks Paulness for the contact information. I e-mailed gzone 08/10/14 02:56:41 PM
#64697   Doug Nelkin & Fraud truthhurts 08/06/14 01:02:09 AM
#64696   Sent an Email still nothing yet. Paulness 07/31/14 12:58:58 PM
#64695   So Paulness... wanaB 07/29/14 04:49:14 PM
#64694   You are correct. Paulness 07/23/14 06:46:46 PM
#64693   In April of 2013, you posted the contact Captain Crunch 07/23/14 06:26:03 PM
#64692   Does anyone know if the investors that are Paulness 07/23/14 05:04:03 PM
#64691   Ok, does this mean that my CYGX stock nw_La 07/21/14 01:11:41 PM
#64690   Thank god - I always liked Plummer the actor! ubernano 07/18/14 04:56:44 PM
#64689   13. Plummer, age 53, was CEO of Franklin scion 07/18/14 04:28:36 PM
#64688   Is that Plummer the actor? ubernano 07/18/14 04:20:09 PM
#64687   The SEC alleges that Christopher Plummer teamed up scion 07/18/14 03:44:27 PM
#64686   gdepc ,did you hear anything about CYGX , Paulness 07/07/14 12:20:10 AM
#64685   Did you see what VNTH is doing ? Paulness 06/19/14 04:26:33 PM
#64684   http://www.bing.com/images/search?q=clare+of+assisi&stid=8741b35d-73b4-4367-a51a Paulness 05/14/14 07:27:21 PM
#64683   Did you ever look into PVCT Provectus looks Paulness 04/18/14 07:09:23 PM
#64682   Paulness, things sometimes change. My experience in holycow 04/17/14 07:34:13 PM
#64681   Sorry you didn't give the baby a chance Paulness 04/17/14 11:12:31 AM
#64680   Paulness, I sold vnth taking a big hit, holycow 04/17/14 10:13:21 AM
#64679   holycow, if you have a little time listen Paulness 04/13/14 08:55:04 PM
PostSubject